Photothermally Amplified Therapeutic Liposomes for Effective Combination Treatment of Cancer

Hwan Jun Yoon, Hye Seong Lee, Jik Han Jung, Hyun Koo Kim, Ji Ho Park

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Near-infrared photothermal therapy has been investigated extensively with regard to selective tumor eradication, yet its clinical translation has been limited because of the absence of FDA-approvable agents with effective phototherapeutic function and minimal systemic toxicity. In this work, we developed photothermally amplified therapeutic liposomes in an attempt to synergize chemotherapy and hyperthermia for effective cancer phototherapy. The anticancer drug cisplatin and the photothermal agent indocyanine green (ICG) were encapsulated in a thermosensitive liposomal formulation at the lipid/ICG ratio maximizing the ICG loading efficiency. These liposomes released cytotoxic cisplatin molecules selectively via ICG-mediated photothermal stimulation. In phototherapeutic studies, these liposomes amplified therapeutic effects both in vitro in cancer cells and in vivo in mouse tumor models significantly over chemotherapy or photothermal therapy alone. We believe that these photothermally amplified therapeutic liposomes composed solely of already FDA-approved components (cisplatin, ICG, and phospholipids) have enormous potential for clinical translation in treating various tumors compatible with laser irradiation.

Original languageEnglish
Pages (from-to)6118-6123
Number of pages6
JournalACS Applied Materials and Interfaces
Volume10
Issue number7
DOIs
Publication statusPublished - 2018 Feb 21

Fingerprint

Indocyanine Green
Liposomes
Tumors
Chemotherapy
Cisplatin
Phospholipids
Laser beam effects
Lipids
Toxicity
Cells
Infrared radiation
Molecules
Pharmaceutical Preparations

Keywords

  • cancer
  • chemotherapy
  • indocyanine green
  • photothermal heating
  • thermosensitive liposome

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Photothermally Amplified Therapeutic Liposomes for Effective Combination Treatment of Cancer. / Yoon, Hwan Jun; Lee, Hye Seong; Jung, Jik Han; Kim, Hyun Koo ; Park, Ji Ho.

In: ACS Applied Materials and Interfaces, Vol. 10, No. 7, 21.02.2018, p. 6118-6123.

Research output: Contribution to journalArticle

Yoon, Hwan Jun ; Lee, Hye Seong ; Jung, Jik Han ; Kim, Hyun Koo ; Park, Ji Ho. / Photothermally Amplified Therapeutic Liposomes for Effective Combination Treatment of Cancer. In: ACS Applied Materials and Interfaces. 2018 ; Vol. 10, No. 7. pp. 6118-6123.
@article{ebec2d9ede344ef1a5af32fd3aff33da,
title = "Photothermally Amplified Therapeutic Liposomes for Effective Combination Treatment of Cancer",
abstract = "Near-infrared photothermal therapy has been investigated extensively with regard to selective tumor eradication, yet its clinical translation has been limited because of the absence of FDA-approvable agents with effective phototherapeutic function and minimal systemic toxicity. In this work, we developed photothermally amplified therapeutic liposomes in an attempt to synergize chemotherapy and hyperthermia for effective cancer phototherapy. The anticancer drug cisplatin and the photothermal agent indocyanine green (ICG) were encapsulated in a thermosensitive liposomal formulation at the lipid/ICG ratio maximizing the ICG loading efficiency. These liposomes released cytotoxic cisplatin molecules selectively via ICG-mediated photothermal stimulation. In phototherapeutic studies, these liposomes amplified therapeutic effects both in vitro in cancer cells and in vivo in mouse tumor models significantly over chemotherapy or photothermal therapy alone. We believe that these photothermally amplified therapeutic liposomes composed solely of already FDA-approved components (cisplatin, ICG, and phospholipids) have enormous potential for clinical translation in treating various tumors compatible with laser irradiation.",
keywords = "cancer, chemotherapy, indocyanine green, photothermal heating, thermosensitive liposome",
author = "Yoon, {Hwan Jun} and Lee, {Hye Seong} and Jung, {Jik Han} and Kim, {Hyun Koo} and Park, {Ji Ho}",
year = "2018",
month = "2",
day = "21",
doi = "10.1021/acsami.7b15996",
language = "English",
volume = "10",
pages = "6118--6123",
journal = "ACS applied materials & interfaces",
issn = "1944-8244",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Photothermally Amplified Therapeutic Liposomes for Effective Combination Treatment of Cancer

AU - Yoon, Hwan Jun

AU - Lee, Hye Seong

AU - Jung, Jik Han

AU - Kim, Hyun Koo

AU - Park, Ji Ho

PY - 2018/2/21

Y1 - 2018/2/21

N2 - Near-infrared photothermal therapy has been investigated extensively with regard to selective tumor eradication, yet its clinical translation has been limited because of the absence of FDA-approvable agents with effective phototherapeutic function and minimal systemic toxicity. In this work, we developed photothermally amplified therapeutic liposomes in an attempt to synergize chemotherapy and hyperthermia for effective cancer phototherapy. The anticancer drug cisplatin and the photothermal agent indocyanine green (ICG) were encapsulated in a thermosensitive liposomal formulation at the lipid/ICG ratio maximizing the ICG loading efficiency. These liposomes released cytotoxic cisplatin molecules selectively via ICG-mediated photothermal stimulation. In phototherapeutic studies, these liposomes amplified therapeutic effects both in vitro in cancer cells and in vivo in mouse tumor models significantly over chemotherapy or photothermal therapy alone. We believe that these photothermally amplified therapeutic liposomes composed solely of already FDA-approved components (cisplatin, ICG, and phospholipids) have enormous potential for clinical translation in treating various tumors compatible with laser irradiation.

AB - Near-infrared photothermal therapy has been investigated extensively with regard to selective tumor eradication, yet its clinical translation has been limited because of the absence of FDA-approvable agents with effective phototherapeutic function and minimal systemic toxicity. In this work, we developed photothermally amplified therapeutic liposomes in an attempt to synergize chemotherapy and hyperthermia for effective cancer phototherapy. The anticancer drug cisplatin and the photothermal agent indocyanine green (ICG) were encapsulated in a thermosensitive liposomal formulation at the lipid/ICG ratio maximizing the ICG loading efficiency. These liposomes released cytotoxic cisplatin molecules selectively via ICG-mediated photothermal stimulation. In phototherapeutic studies, these liposomes amplified therapeutic effects both in vitro in cancer cells and in vivo in mouse tumor models significantly over chemotherapy or photothermal therapy alone. We believe that these photothermally amplified therapeutic liposomes composed solely of already FDA-approved components (cisplatin, ICG, and phospholipids) have enormous potential for clinical translation in treating various tumors compatible with laser irradiation.

KW - cancer

KW - chemotherapy

KW - indocyanine green

KW - photothermal heating

KW - thermosensitive liposome

UR - http://www.scopus.com/inward/record.url?scp=85042545817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042545817&partnerID=8YFLogxK

U2 - 10.1021/acsami.7b15996

DO - 10.1021/acsami.7b15996

M3 - Article

VL - 10

SP - 6118

EP - 6123

JO - ACS applied materials & interfaces

JF - ACS applied materials & interfaces

SN - 1944-8244

IS - 7

ER -